KPV Peptide for Lyme Disease: Healing Beyond Antibiotics
Written by Dr. Diane Mueller Peptide therapy for Lyme disease, including the use of KPV peptide, is not just another supplement in the long list of experimental treatments. Unlike antibiotics, which target the infection directly, KPV addresses the secondary damage Lyme leaves behind: immune overactivation, hormone disruption, and gut dysfunction. This peptide fragment of alpha-MSH […]
LL-37 Peptide Lyme Disease Insights: Cathelicidin Therapy for Biofilm Disruption and More
Written by Dr. Diane Mueller Peptide therapy, like using LL-37 (also called cathelicidin), is catching attention as a new way to tackle Lyme disease when standard antibiotics aren’t enough. Lyme disease, caused by the Borrelia burgdorferi bacteria, can leave people dealing with lingering issues like fatigue, joint pain, and brain fog, even after treatment. LL-37 […]
